Which statement describes AEGL-1?

• A. Airborne concentration above which general population could experience notable discomfort, irritation, or certain non-sensory effects, reversible upon cessation
• B. Airborne concentration above which general population could experience irreversible health effects
• C. Airborne concentration above which life-threatening health effects or death occur
• D. No health effects at any concentration

Answer: (A)

The main idea here is AEGL-1, which marks the exposure level at which the general population could begin to experience mild, noticeable effects that are not life-threatening and would be reversible after the exposure ends. It covers things like irritation or other non-sensory effects that cause discomfort but aren’t permanent. This level is intentionally lower than the more severe AEGLs to provide an early warning and protect people from experiencing bothersome symptoms during a release.

That’s why the statement describing airborne concentration above which people could experience notable discomfort, irritation, or certain non-sensory effects, reversible upon cessation, is the best fit. It distinguishes AEGL-1 as measuring mild, reversible effects rather than irreversible harm or life-threatening outcomes.

To contrast with the other ideas: a statement about irreversible health effects would align with a higher AEGL level (AEGL-2), while one about life-threatening effects or death corresponds to the highest level (AEGL-3). The idea of no health effects at any concentration does not describe any AEGL threshold.